Quick answer
Te Connectivity Plc (TEL) reported revenue of $17.26B and net income of $1.84B for the fiscal year ended 2025-09-26, up 8.9% from $15.85B the year before, per its 10-K filed with the SEC on 2025-11-10. Long-term debt stood at $4.84B.
Data as of 2025-09-26. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Fiscal year | Revenue | Net income | Long-term debt |
|---|---|---|---|
| 2025 (FY ending 2025-09-26) | $17.26B | $1.84B | $4.84B |
| 2024 (FY ending 2024-09-27) | $15.85B | $3.19B | $3.33B |
| 2023 (FY ending 2023-09-29) | $16.03B | $1.91B | $3.53B |
| 2022 (FY ending 2022-09-30) | $16.28B | $2.43B | $3.29B |
| 2021 (FY ending 2021-09-24) | $14.92B | $2.26B | $3.59B |
| 2020 (FY ending 2020-09-25) | $12.17B | -$241.0M | $3.45B |
| 2019 (FY ending 2019-09-27) | $13.45B | $1.84B | $3.40B |
| 2018 (FY ending 2018-09-28) | $13.99B | $2.56B | $4.00B |
| 2017 (FY ending 2017-09-29) | $12.19B | $1.68B | $4.34B |
| 2016 (FY ending 2016-09-30) | $11.35B | $2.01B | $4.07B |
Related
- TDG revenue, net income and debt history (TransDigm Group Incorporated)
- TDY revenue, net income and debt history (Teledyne Technologies Inc)
- TEAM revenue, net income and debt history (Atlassian Corporation)
- TEM revenue, net income and debt history (Tempus AI, Inc.)
- TER revenue, net income and debt history (Teradyne, Inc.)
- TEVA revenue, net income and debt history (Teva Pharmaceutical Industries Limited)
- TGT revenue, net income and debt history (Target Corporation)
- TGTX revenue, net income and debt history (Tg Therapeutics, Inc.)
Last updated Oct 16, 2026, 10:42 PM ET. Data only, not financial or tax advice.
Related answers
- TEL dividend history: TE Connectivity plc annual dividends per share
- TEL earnings report dates and EPS history (Te Connectivity Plc)